After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Quest Diagnostics, Inc is listed on the NYSE in the Healthcare sector while operating in the Diagnostics & Research industry. The current market capitalization of Quest Diagnostics, Inc is $18.23B. A total of 2.3 million shares were traded on the day, compared to an average of 1.16M shares.
In the most recent transaction, Davis J. E. sold 39,191 shares of DGX for 168.46 per share on Apr 02 ’25. After the transaction, the CEO and President now owns 127,623 company shares. In a previous transaction on Apr 02 ’25, KUPPUSAMY KARTHIK sold 2,555 shares at 170.00 per share. DGX shares that SVP, Clinical Solutions owns now total 10,575.
Among the insiders who bought shares, Davis J. E. acquired of 39,191 shares on Apr 02 ’25 at a per-share price of $170.00. In another insider transaction, KUPPUSAMY KARTHIK bought 2,555 shares at $170.00 per share on Apr 02 ’25.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Quest Diagnostics, Inc pays an annual dividend of $3.05, resulting in a dividend yield of 1.86%, and it has a price to earnings (P/E) ratio of 21.35. DGX’s most recent ex-dividend date was 2.06% when it declared a $0.80 quarterly dividend that was paid in cash on 4/7/2025. Previously, the company paid the dividend on 1/14/2025 with an ex-dividend date of 1.85%. The DGX stock dividend was $0.75 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, DGX has a high of $178.87 and a low of $125.42.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. DGX’s latest balance sheet shows that the firm has $872.00M in Cash & Short Term Investments as of fiscal 2021. There were $4.77B in debt and $1.75B in liabilities at the time. Its Book Value Per Share was $61.06, while its Total Shareholder’s Equity was $6.56B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DGX is Buy with a score of 4.06.
